Allyson Mayer

Senior Investment Analyst, BioGenerator Ventures at BioSTL

Allyson is an analyst on the BioGenerator team and part of the Center for Defense Medicine. In this role, she works to identify, support, and commercialize technologies with applications to military and civilian health, with the goal of creating new successful companies in St. Louis.

Prior to BioGenerator, Allyson was a computational biologist for PercayAI, a St. Louis-based startup developing software that integrates biomedical data to enable faster and more effective drug discovery. Allyson also brings experience in project management and clinical pharmacology from her time as a project manager for Nuventra Pharma Sciences.

Allyson holds a PhD in Developmental, Regenerative, and Stem Cell Biology from Washington University in St. Louis, where she was a National Science Foundation Graduate Research Fellow and a Spencer T. and Ann W. Olin Fellow. Her thesis work focused on the identification and application of novel hepatic metabolic pathways to treat cardiometabolic disease.

Timeline

  • Senior Investment Analyst, BioGenerator Ventures

    Current role

  • Analyst, Center for Defense Medicine

  • Analyst, BioGenerator Ventures